TrialClinical infectious diseases : an official publication of the Infectious Diseases Society of America2025

PUNCH CD3-OLS: A Phase 3 Prospective Observational Cohort Study to Evaluate the Safety and Efficacy of Fecal Microbiota, Live-jslm (REBYOTA) in Adults With Recurrent Clostridioides difficile Infection.

Paul Feuerstadt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.